Marcilla et al., 2014 - Google Patents
Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residueMarcilla et al., 2014
View HTML- Document ID
- 7925600028001457570
- Author
- Marcilla M
- Alpízar A
- Lombardía M
- Ramos-Fernandez A
- Ramos M
- Albar J
- Publication year
- Publication venue
- Molecular & Cellular Proteomics
External Links
Snippet
Human leukocyte antigen (HLA) class I molecules bind peptides derived from the intracellular degradation of endogenous proteins and present them to cytotoxic T lymphocytes, allowing the immune system to detect transformed or virally infected cells. It is …
- 102000004196 processed proteins & peptides 0 title abstract description 73
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Marcilla et al. | Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residue | |
Purcell et al. | Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics | |
Chong et al. | High-throughput and sensitive immunopeptidomics platform reveals profound interferonγ-mediated remodeling of the human leukocyte antigen (HLA) ligandome | |
Hassan et al. | The human leukocyte antigen–presented ligandome of B lymphocytes | |
Barber et al. | Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes | |
Lee et al. | Architecture mapping of the inner mitochondrial membrane proteome by chemical tools in live cells | |
Purcell et al. | Immunoproteomics: mass spectrometry-based methods to study the targets of the immune response | |
Alpízar et al. | A molecular basis for the presentation of phosphorylated peptides by HLA-B antigens | |
Zarling et al. | Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo | |
Pierce et al. | Cutting edge: the HLA-A* 0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique | |
Sofron et al. | High‐resolution analysis of the murine MHC class II immunopeptidome | |
Ritz et al. | High‐sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients’ sera | |
Udaka et al. | An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries | |
Chen et al. | Identification of MHC peptides using mass spectrometry for neoantigen discovery and cancer vaccine development | |
Schumacher et al. | Building proteomic tool boxes to monitor MHC class I and class II peptides | |
Mester et al. | Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands | |
Petrotchenko et al. | Use of proteinase K nonspecific digestion for selective and comprehensive identification of interpeptide cross-links: application to prion proteins | |
Jarmalavicius et al. | High immunogenicity of the human leukocyte antigen peptidomes of melanoma tumor cells | |
Pritchard et al. | Exploration of peptides bound to MHC class I molecules in melanoma | |
Giam et al. | A comprehensive analysis of peptides presented by HLA‐A1 | |
Gebreselassie et al. | Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B* 5101 with peptides | |
EP1105731B1 (en) | Profiling and cataloging expressed protein tags | |
Espinosa et al. | Peptides presented by HLA class I molecules in the human thymus | |
Mangalaparthi et al. | Digging deeper into the immunopeptidome: characterization of post-translationally modified peptides presented by MHC I | |
Antwi et al. | Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines |